专利信息

首页 1 2 3 下页尾页共 24 条记录, 当前第1/3页。

专利标题：Rimexolone eye drop

专利标题：Use of rimexolone in the treatment of dry eye

专利权人：Alcon, Inc.;

Topical ophthalmic compositions and methods for treating dry eye are described. The compositions and methods of the invention are based on the finding that the oculosurface selective properties of the glucocorticoid rimexolone make this anti-inflammatory agent particularly well-suited for treating dry eye. As a result of the limited ability of rimexolone to penetrate the cornea a high portion of the drug remains on the surface of t he eye which is the primary locus of the inflammatory conditions...

专利标题：Use of rimexolone in the treatment of dry eye

专利权人：Alcon, Inc.;

专利标题：Use of rimexolone in the treatment of dry eye

专利权人：Alcon, Inc.;

专利标题：Use of rimexolone in the treatment of dry eye

专利权人：Alcon, Inc.;

专利标题：Use of rimexolone in the treatment of dry eye

专利权人：Alcon, Inc.;

Topical ophthalmic compositions and methods for treating dry eye are described.The compositions and methods of the invention are based on the finding that the oculosurface selective properties of the glucocorticoid rimexolone make this anti-inflammatory agent particularly well-suited for treating dry eye.As a result of the limited ability of rimexolone to penetrate the cornea a high portion of the drug remains on the surface of the eye which is the primary locus of the inflammatory conditions as...

专利标题：Use of rimexolone in the treatment of dry eye

专利权人：Alcon, Inc.;

Topical ophthalmic compositions and methods for treating dry eye are described. The compositions and methods of the invention are based on the finding that the oculosurface selective properties of the glucocorticoid rimexolone make this anti-inflammatory agent particularly well-suited for treating dry eye. As a result of the limited ability of rimexolone to penetrate the cornea a high portion of the drug remains on the surface of the eye which is the primary locus of the inflammatory conditions ...

专利标题：Use of rimexolone in the treatment of dry eye

专利权人：Alcon, Inc.;

专利标题：Use of rimexolone in the treatment of dry eye

专利权人：Alcon, Inc.;

Topical ophthalmic compositions and methods for treating dry eye are described. The compositions and methods of the invention are based on the finding that the oculosurface selective properties of the glucocorticoid rimexolone make this anti-inflammatory agent particularly well-suited for treating dry eye. As a result of the limited ability of rimexolone to penetrate the cornea a high portion of the drug remains on the surface of the eye which is the primary locus of the inflammatory conditions ...

专利标题：Application of rimexolone for dry eye syndrome treatment

专利权人：Al'kon, Ink.;

FIELD: medicine; ophthalmology. ^ SUBSTANCE: applied compositions contain corticosteroid Rimexolone in concentration 0.001 to 0.1% mass/vl. ^ EFFECT: effective treatment of dry eye syndrome is provided at minimum by-effects due to limited eye penetrability of agent. ^ 19 cl 4 dwg 4 ex 2 tbl

当前查询条件: [药品] 包含 'Rimexolone'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

	1. CN103565739A	2014/2/12
	专利标题：Rimexolone eye drop 专利权人：

	2. CA2507375C	2009/11/24
	专利标题：Use of rimexolone in the treatment of dry eye 专利权人：Alcon, Inc.; Topical ophthalmic compositions and methods for treating dry eye are described. The compositions and methods of the invention are based on the finding that the oculosurface selective properties of the glucocorticoid rimexolone make this anti-inflammatory agent particularly well-suited for treating dry eye. As a result of the limited ability of rimexolone to penetrate the cornea a high portion of the drug remains on the surface of t he eye which is the primary locus of the inflammatory conditions...

	3. AU2003299696B2	2009/8/13
	专利标题：Use of rimexolone in the treatment of dry eye 专利权人：Alcon, Inc.;

	4. SI1575597T1	2009/4/30
	专利标题：Use of rimexolone in the treatment of dry eye 专利权人：Alcon, Inc.;

	5. HK1076248A1	2009/4/17
	专利标题：Use of rimexolone in the treatment of dry eye 专利权人：Alcon, Inc.;

	6. KR100889170B1	2009/3/16
	专利标题：Use of rimexolone in the treatment of dry eye 专利权人：Alcon, Inc.; Topical ophthalmic compositions and methods for treating dry eye are described.The compositions and methods of the invention are based on the finding that the oculosurface selective properties of the glucocorticoid rimexolone make this anti-inflammatory agent particularly well-suited for treating dry eye.As a result of the limited ability of rimexolone to penetrate the cornea a high portion of the drug remains on the surface of the eye which is the primary locus of the inflammatory conditions as...

	7. KR20090018222A	2009/2/19
	专利标题：Use of rimexolone in the treatment of dry eye 专利权人：Alcon, Inc.; Topical ophthalmic compositions and methods for treating dry eye are described. The compositions and methods of the invention are based on the finding that the oculosurface selective properties of the glucocorticoid rimexolone make this anti-inflammatory agent particularly well-suited for treating dry eye. As a result of the limited ability of rimexolone to penetrate the cornea a high portion of the drug remains on the surface of the eye which is the primary locus of the inflammatory conditions ...

	8. PT1575597E	2009/2/2
	专利标题：Use of rimexolone in the treatment of dry eye 专利权人：Alcon, Inc.;

	9. EP1575597B1	2009/1/7
	专利标题：Use of rimexolone in the treatment of dry eye 专利权人：Alcon, Inc.; Topical ophthalmic compositions and methods for treating dry eye are described. The compositions and methods of the invention are based on the finding that the oculosurface selective properties of the glucocorticoid rimexolone make this anti-inflammatory agent particularly well-suited for treating dry eye. As a result of the limited ability of rimexolone to penetrate the cornea a high portion of the drug remains on the surface of the eye which is the primary locus of the inflammatory conditions ...

	10. RU2330668C2	2008/8/10
	专利标题：Application of rimexolone for dry eye syndrome treatment 专利权人：Al'kon, Ink.; FIELD: medicine; ophthalmology. ^ SUBSTANCE: applied compositions contain corticosteroid Rimexolone in concentration 0.001 to 0.1% mass/vl. ^ EFFECT: effective treatment of dry eye syndrome is provided at minimum by-effects due to limited eye penetrability of agent. ^ 19 cl 4 dwg 4 ex 2 tbl

下载范围

下载内容